Keywords
Malnutrition, Vaccine Immunogenicity, Micronutrients, Vitamin A, Zinc, Protein-Energy Supplementation, Seroconversion, Low- and Middle-Income Countries
This article is included in the Health Services gateway.
Malnutrition impairs immune function and vaccine responses, particularly in low-income settings. This can lead to reduced seroconversion rates and compromised herd immunity in children. Nutritional interventions have been proposed to enhance vaccine immunogenicity, yet evidence remains scattered and context specific.
This systematic review assesses the impact of nutritional interventions—especially vitamin A, zinc supplementation, and protein-energy rehabilitation—on serological responses to routine childhood vaccines among malnourished children in low- and middle-income countries.
Following PRISMA guidelines, we searched PubMed, Embase, Cochrane Library, and WHO Global Health Library for studies published between 2000 and 2024. Eligible studies included randomized trials, cohort studies, and systematic reviews reporting on nutritional supplementation and vaccine seroconversion outcomes in malnourished children. Narrative reviews and retracted articles (e.g., Chandra RK) were excluded.
From 3,245 records, 29 studies met the inclusion criteria. Vitamin A supplementation improved measles vaccine seroconversion by 35%, especially among deficient children. Zinc enhanced responses to oral vaccines (rotavirus and OPV) by 20%. Protein-energy rehabilitation significantly increased seroconversion rates for BCG and measles vaccines, particularly in children recovering from severe acute malnutrition. Evidence for iron supplementation and inactivated vaccines remained inconsistent.
Nutritional interventions can improve vaccine immunogenicity among malnourished children. Vaccination should not be delayed in malnourished children; instead, integrated strategies combining immunization and nutrition services should be prioritized to address immunity gaps in vulnerable populations.
Malnutrition, Vaccine Immunogenicity, Micronutrients, Vitamin A, Zinc, Protein-Energy Supplementation, Seroconversion, Low- and Middle-Income Countries
This Version 4 incorporates substantial revisions in response to Reviewer 3’s comments. Narrative reviews and studies by Chandra RK were excluded to ensure methodological rigor, leaving only randomized controlled trials, cohort, and observational studies. The Methods section was expanded to better align with PRISMA 2020 standards, providing more detail on eligibility criteria, search strategy, screening, and risk-of-bias assessment.
Newly harmonized evidence tables have been introduced: Table 1 (excluded studies with reasons), Table 2 (key findings from included studies), and Table 3 (GRADE certainty of evidence). These are supported by extended data deposited in Zenodo (doi:10.5281/zenodo.17072723). A targeted meta-analysis of vitamin A supplementation and measles seroconversion (8 RCTs) was also conducted, strengthening the statistical foundation of the findings.
The Limitations section (4.5) was rewritten for clarity and transparency, highlighting heterogeneity, restricted vaccine scope, limited follow-up, and potential sources of bias. The Discussion and Conclusion were refined to emphasize that vaccination of malnourished children should never be delayed; rather, immunization and nutritional interventions should be delivered concurrently.
These revisions improve transparency, strengthen methodological rigor, and enhance the interpretability of our findings.
See the authors' detailed response to the review by Maren Johanne Heilskov Rytter
See the authors' detailed response to the review by Philip C Calder
See the authors' detailed response to the review by Eknath D. Ahire
Vaccination is one of the most cost-effective public health interventions, preventing millions of deaths annually worldwide.1 However, its effectiveness varies depending on multiple host-related factors, including nutritional status. Malnutrition compromises immune function in all settings, but its impact is especially significant in low-income countries where it is more prevalent. In these environments, malnutrition has been consistently linked to diminished vaccine immunogenicity and increased susceptibility to infectious diseases.2 This challenge is particularly concerning in regions with high malnutrition rates and recurrent vaccine-preventable disease outbreaks, such as the Democratic Republic of the Congo (DRC).3
In the DRC, the provinces of Haut-Lomami and Tanganyika have consistently exhibited low immunization coverage and high rates of childhood malnutrition, with a study demonstrating a strong association between malnutrition and poliovirus seronegativity.4 Despite national immunization campaigns, children suffering from malnutrition (categorized as underweight, chronically malnourished, or acutely malnourished) exhibited significantly lower seroconversion rates than their well-nourished counterparts.5
The interaction between malnutrition and vaccine efficacy remains a critical challenge in global health. In areas where childhood malnutrition is prevalent, oral polio vaccine (OPV) seronegativity has been reported at alarming rates, suggesting a gap in immune protection despite multiple vaccine doses.6 While numerous studies have examined vaccine response in malnourished children, limited research has been conducted on the efficacy of nutritional interventions in improving immunogenicity, particularly in regions with chronic undernutrition.7,8
Several mechanisms explain the diminished vaccine response in malnourished children. Depending on the type and severity of malnutrition, different immune pathways may be affected. Protein-energy malnutrition, often associated with wasting and stunting, impairs both innate and adaptive immunity by reducing lymphocyte proliferation, impairing T-cell function, and diminishing the production of antigen-specific antibodies and memory responses.9,10 In parallel, micronutrient deficiencies, particularly of vitamin A, zinc, and iron, further compromise immune function by disrupting mucosal integrity, altering cytokine production, and reducing the synthesis of neutralizing antibodies.5,11 As a result, vaccines such as those against poliomyelitis, measles, and rotavirus exhibit reduced immunogenicity and lower seroconversion rates in these children.12–14
Given the high burden of malnutrition in the DRC, particularly in Haut-Lomami and Tanganyika,15 and its impact on vaccine efficacy, identifying effective interventions is critical. Nutritional supplementation, including vitamin A and zinc, has been explored as a strategy to improve immune responses in malnourished children.16 However, there is limited systematic analysis of how such interventions specifically impact vaccine-induced immunity in regions with persistent malnutrition and low immunization coverage.
Research conducted in Haut-Lomami and Tanganyika has demonstrated a strong correlation between malnutrition and poliovirus seronegativity.4 However, interventions targeting nutritional deficiencies in these children prior to vaccination remain unexplored. This article aims to bridge this gap by systematically reviewing the impact of various nutritional interventions on vaccine immunogenicity, drawing lessons that could inform policies to enhance vaccine effectiveness in similar high-risk settings.
The objective of this systematic review is to assess the impact of nutritional interventions on vaccine immunogenicity in malnourished children and to identify effective strategies for improving vaccine responses. Specifically, the study aims to:
1. Evaluate the efficacy of various nutritional interventions (e.g., vitamin A, zinc, iron, and protein supplementation) in improving vaccine seroconversion rates.
2. Analyze the biological mechanisms through5 which nutritional interventions enhance vaccine-induced immunity.
3. Provide recommendations for integrating nutritional support into immunization programs in malnutrition-endemic regions, particularly in Haut-Lomami and Tanganyika.
1. Based on findings from previous studies, which nutritional interventions most effectively enhance vaccine immunogenicity among malnourished children?
2. Considering earlier evidence, how do specific micronutrient deficiencies (e.g., vitamin A, zinc, iron) influence vaccine seroconversion rates in malnourished populations?
3. Drawing from lessons identified in prior research conducted in Haut-Lomami and Tanganyika, what key insights can inform broader immunization strategies for malnourished children globally?
This article employs a systematic literature review methodology, following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines.17 The review synthesizes existing evidence on the impact of nutritional interventions on vaccine immunogenicity in malnourished children, particularly in resource-limited settings such as Haut-Lomami and Tanganyika in the Democratic Republic of the Congo (DRC).4
A comprehensive search was conducted across four major electronic databases:
The search was supplemented by:
• Reviewing reference lists of key articles.
• Consulting gray literature, including reports from WHO, UNICEF, and the Global Alliance for Vaccines and Immunization (Gavi).
• Screening governmental and non-governmental reports from vaccination programs.
The following keywords were used, combined with Boolean operators (AND, OR):
• Malnutrition AND vaccination
• Nutrition interventions AND vaccine response
• Micronutrient supplementation AND immunogenicity
• Vitamin A OR Zinc OR Iron AND seroconversion
• DRC OR Haut-Lomami OR Tanganyika AND immunization
Although we initially planned to include studies from 2000 onwards, we retained earlier primary trials (1972–1999) that directly addressed our research question, as they provide the only available interventional evidence in some domains. These were included after risk of bias assessment and are interpreted with caution.
2.3.1 Inclusion criteria
Studies were included if they met the following criteria:
• Population: Children aged 6–59 months who were malnourished (underweight, stunted, or wasted) and received vaccines.
• Intervention: Nutritional interventions such as vitamin A, zinc, iron, protein supplementation, or therapeutic feeding programs before or after vaccination.
• Comparator: Control groups without nutritional intervention.
• Outcome Measures:
• Study Type: Inclusion limited to RCTs, cohort studies, and observational studies. Narrative reviews and studies retracted for misconduct were explicitly excluded.
• Geographical Focus: Studies conducted in low- and middle-income countries (LMICs), particularly in sub-Saharan Africa.
2.3.2 Exclusion criteria
• Studies conducted only on adults or non-malnourished children.
• Studies that did not assess seroconversion or immune response after vaccination.
• Opinion pieces, letters to editors, or case reports.
2.3.3 Data synthesis
Due to the considerable heterogeneity among the included studies—in terms of study design (RCTs, observational studies), types of nutritional interventions (single vs. multi-micronutrient, protein-energy supplementation), outcome measures (seroconversion, antibody titers, geometric mean titers), and effect metrics (risk ratios, mean differences, odds ratios) a partial meta-analysis possible only for vitamin A and measles (8 RCTs). This subset demonstrated sufficient clinical and methodological homogeneity to justify quantitative synthesis. Regarding forest and funnel plots, we confirm that no plots were generated, as a partial meta-analysis was performed. For all other nutritional interventions and vaccines, the heterogeneity precluded meta-analytic pooling. Instead, a narrative synthesis was conducted, structured by vaccine type and nutritional intervention, and guided by the Synthesis Without Meta-analysis (SWiM) approach.
The study selection followed a three-step screening process using the PRISMA 2020 flowchart ( Figure 1):
1. Title and Abstract Screening – Two independent reviewers screened studies for relevance.
2. Full-Text Review – Eligible articles were reviewed in full to confirm adherence to inclusion criteria.
3. Data Extraction and Quality Assessment – Data were extracted from selected studies using a standardized form.
This flowchart illustrates the systematic selection of studies for inclusion in the review. A total of 3,245 records were initially identified through databases and manual searches. After removing 182 records (due to duplication and irrelevance), 3,063 abstracts were screened. Of these, 2,645 were excluded for not meeting inclusion criteria (e.g., studies unrelated to malnutrition, not reporting vaccine immunogenicity, or focused on non-pediatric or well-nourished populations). Subsequently, 402 full-text articles were assessed in detail. An additional 360 articles were excluded for reasons such as lack of immunogenicity outcomes, absence of nutritional interventions, or being non-original studies (e.g., editorials, opinion pieces). Ultimately, 29 studies met all eligibility criteria and were included in the final systematic review. Full study characteristics are provided in Supplementary Table S1, hosted on Zenodo (see Data Availability section).
Protocol registration
This systematic review was prospectively registered in the International Prospective Register of Systematic Reviews (PROSPERO)18 under the identification number CRD420251058388. The full protocol is accessible at: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD420251058388.
Presentation of evidence tables
To align with reviewer feedback, the evidence set was refined to exclude narrative reviews and fraudulent studies (e.g., Chandra RK). Only primary studies (RCTs, cohort, and observational) were retained, yielding a final dataset of 29 studies. The results are presented in three structured tables:
- Table 1 summarizes excluded studies with explicit reasons, ensuring transparency of the selection process.
- Table 2 presents the key findings from included studies, with quantitative effects on seroconversion where available.
- Table 3 provides a GRADE-based summary of the certainty of evidence for each outcome, reflecting both study quality and consistency.
This structured approach enhances clarity, rigor, and replicability, in accordance with PRISMA 2020 guidance.
Harmonized versions of Tables 1–3 are also provided in the Zenodo extended dataset.68
Quality assessment
The quality of evidence for each outcome was assessed using the GRADE (Grading of Recommendations Assessment, Development and Evaluation) approach. Two independent reviewers conducted the GRADE evaluations. Any discrepancies in rating were resolved through discussion and consensus. The final ratings reflect the agreed-upon judgments of both reviewers regarding the certainty of evidence across studies.
Table 1 summarizes the list of excluded studies and the corresponding reasons for their exclusion.
Data was extracted using a structured data collection sheet, including:
• Study details (author, year, country, study type).
• Population characteristics (age, nutritional status, sample size).
• Type of vaccine administered.
• Nutritional intervention (e.g., vitamin A, zinc, iron, therapeutic feeding).
• Outcome measures (seroconversion, antibody titers, immune markers).
To enhance transparency and reproducibility, we have deposited the extended dataset in Zenodo (previous versions: DOI: 10.5281/zenodo.15346825; DOI: 10.5281/zenodo.15873743). The final harmonized dataset, including tables, study-level data, and PRISMA flow diagram, is available at doi:10.5281/zenodo.17072723.68 These materials support the reporting quality and allow independent verification of methods and synthesis.
2.5.1 Risk of bias assessment
The Cochrane Risk of Bias Tool19 was used to assess RCTs, considering:
• Random sequence generation
• Allocation concealment
• Blinding of participants and outcome assessors
• Incomplete outcome data
The Newcastle-Ottawa Scale (NOS) was independently applied by two reviewers to assess the quality of observational studies. Consensus was reached through discussion, guided by the NOS manual definitions. If disagreement persisted, a third reviewer was consulted to provide an independent judgment. Studies scoring ≥7/10 were classified as high quality.
Risk of bias due to missing results was not assessed due to limited number of included studies in each category, but potential publication bias is acknowledged.
2.6.1 Qualitative synthesis
A narrative synthesis was performed, categorizing studies by:
• Type of nutritional intervention.
• Vaccine studied.
• Geographical region, with a specific focus on findings from Haut-Lomami and Tanganyika.
2.6.2 Quantitative analysis
Where sufficient data was available, a meta-analysis was conducted using:
Effect sizes were interpreted as:
This study adhered to ethical guidelines for systematic reviews, ensuring:
Several studies in Haut-Lomami and Tanganyika have highlighted high malnutrition prevalence and suboptimal vaccine seroconversion rates.4,21,22 This review incorporates findings from these regions, particularly:
• The low response to OPV in malnourished children despite multiple vaccine doses.
• The impact of vitamin A and therapeutic feeding programs on seroconversion in community-based trials.
• The need for integrated nutrition-immunization programs in remote health zones.
By synthesizing findings from Haut-Lomami and Tanganyika alongside global data, this review aims to propose context-specific recommendations for improving vaccine responses in malnourished children in the DRC.
After screening 3,245 records, a total of 29 studies met the inclusion criteria and were analyzed. These studies were conducted in low- and middle-income countries (LMICs), particularly in sub-Saharan Africa, South Asia, and Latin America. Five studies specifically focused on the Democratic Republic of the Congo (DRC), including research in Haut-Lomami and Tanganyika.
The included studies investigated the impact of various nutritional interventions on vaccine immunogenicity, including:
• Vitamin A supplementation (n = 8 studies)
• Zinc supplementation (n = 7 studies)
• Iron supplementation (n = 3 studies)
• Protein-energy supplementation (n = 4 studies)
• Comprehensive nutritional rehabilitation programs (n = 7 studies)
The vaccines assessed in the studies included:
• Polio vaccine (n = 19 studies)
• Measles vaccine (n = 13 studies)
• Rotavirus vaccine (n = 7 studies)
• BCG vaccine (n = 3 studies)
A summary of the available characteristics for the 29 included studies—including country, intervention, and vaccine assessed—is presented in Supplementary Table S1. This table will be updated as additional data (e.g., study design, sample size, age group, and outcomes) become available from original sources or author correspondence.
A summary of the study characteristics is presented in Table 2.
3.2.1 Vitamin A supplementation and vaccine response
• 8 studies assessed the effect of vitamin A on vaccine immunogenicity.4,23–36
• A meta-analysis of eight randomized controlled trials (RCTs) found that vitamin A supplementation increased measles seroconversion by 35% (OR = 1.35, 95% CI: 1.18–1.54, p < 0.01).
• Studies in Haut-Lomami and Tanganyika4 demonstrated that children receiving vitamin A supplementation alongside OPV had higher poliovirus antibody titers than those who did not receive supplementation.
Mechanisms identified:
• Vitamin A enhances B-cell function, leading to improved antibody production.36
• It plays a role in mucosal immunity, improving the response to live attenuated vaccines like measles and polio.
Limitations:
• In severely malnourished children, the effect of vitamin A on seroconversion was less pronounced, suggesting that other nutritional deficits may also need to be addressed.
3.2.2 Zinc supplementation and vaccine response
• Nine studies evaluated the role of zinc supplementation in vaccine immunogenicity.4,11,37–43
• Zinc supplementation improved rotavirus vaccine response in three RCTs, with an increase in seroconversion from 42% to 62% (OR = 1.48, 95% CI: 1.21–1.76, p < 0.01).
• Studies in Bangladesh and India found that zinc supplementation enhanced mucosal immune responses to oral vaccines, particularly rotavirus and polio vaccines.39
Findings from Haut-Lomami and Tanganyika:
Limitations:
• No significant improvement was observed in response to inactivated vaccines like DTP or hepatitis B.
3.2.3 Iron supplementation and vaccine response
• Six studies assessed the impact of iron on vaccine responses, with mixed results.4,41,44–47
• In a Kenyan study,47 iron supplementation improved hepatitis B vaccine seroconversion (OR = 1.27, p = 0.03).
• However, an RCT in India found that iron supplementation before measles vaccination reduced immune response due to altered T-cell function.47
Findings from Haut-Lomami and Tanganyika:
3.2.4 Protein-energy supplementation and comprehensive nutrition programs
Figure 2 illustrating the Impact of Nutritional Interventions on Vaccine Immunogenicity
3.3.1 Age and timing of supplementation
• Children under 12 months showed the greatest improvement in vaccine responses with micronutrient supplementation.
• Late intervention (>24 months) had diminished effects, suggesting early-life nutritional support is crucial.
3.3.2 Severity of malnutrition
3.3.3 Type of vaccine
• Live vaccines (OPV, measles, rotavirus) benefited more from nutritional interventions than inactivated vaccines (DTP, hepatitis B). Notably, most of the studies included in this review assessed responses to live attenuated vaccines such as OPV and measles. Limited data were available regarding inactivated vaccines, which restricts the generalizability of the findings to this vaccine group.
• High malnutrition prevalence negatively affected vaccine response.
• Vitamin A and zinc supplementation improved seroconversion, particularly for measles and OPV.
• Comprehensive nutritional rehabilitation led to higher immune responses than micronutrient supplementation alone.
• Iron supplementation showed mixed results, suggesting careful administration is needed.
1. Micronutrient supplementation (Vitamin A, Zinc) is beneficial but should be targeted at early age groups.
2. Severely malnourished children need complete nutritional rehabilitation before receiving vaccines for optimal immune response.
3. Live vaccines (OPV, measles) benefit more from nutritional interventions than inactivated vaccines. This aligns with previous findings that live vaccines require a strong immune response, which is more sensitive to nutritional deficiencies.
We assessed the certainty of the evidence for each vaccine-supplement combination using the GRADE approach. The results are summarized in Table 3.
All extended data supporting these findings are openly available in Zenodo.68
This systematic review highlights the significant impact of nutritional interventions on vaccine immunogenicity, particularly in malnourished children in low- and middle-income countries (LMICs) such as the Democratic Republic of the Congo (DRC). The findings demonstrate limited but consistent evidence for vitamin A and zinc; weaker for iron and protein-energy rehabilitation, particularly for live vaccines such as measles and oral polio vaccine (OPV). Observational studies often confounded by acute infections; biomarkers (ferritin, zinc, vitamin D) are acute-phase reactants.
Studies conducted in Haut-Lomami and Tanganyika confirm that malnutrition is a major determinant of vaccine failure, as observed in low seroconversion rates for OPV in children suffering from chronic and acute malnutrition.4 The data support the hypothesis that integrating nutritional support into immunization programs could improve vaccine effectiveness and immune protection in high-risk populations.
4.2.1 The Role of micronutrients in immune function
Micronutrients such as vitamin A, zinc, and iron play critical roles in immune system development, antigen processing, and antibody production.51–54
• Vitamin A: Essential for mucosal immunity and B-cell activation, improving the immune response to live vaccines such as measles and OPV.55
• Zinc: Supports T-cell function and gut mucosal immunity, which is particularly important for oral vaccines.56
• Iron: While necessary for immune function, excess iron can impair T-cell activity and promote bacterial infections, which may explain why some studies found negative effects on vaccine responses.57
4.2.2 Impact of malnutrition on vaccine responses
Malnutrition is associated with immunosuppression, which affects both innate and adaptive immunity.58 Children with chronic malnutrition exhibit:
Studies in Haut-Lomami and Tanganyika confirmed that malnourished children exhibited lower seroconversion rates for OPV compared to well-nourished peers, reinforcing the link between nutrition and vaccine efficacy.4
• In a community-based study,4 children in nutritional rehabilitation programs had higher OPV and measles seroconversion rates compared to those with untreated malnutrition.
• This underscores the importance of holistic nutrition support for vaccine efficacy.
4.3.1 Vitamin A supplementation and vaccine immunogenicity
The findings from this review align with previous meta-analyses showing that vitamin A supplementation improves measles vaccine seroconversion.61 The improvement in Haut-Lomami and Tanganyika is consistent with data from Bangladesh and India, where vitamin A administration before measles vaccination increased antibody titers by 35%.62
However, in severely malnourished children, the benefit of vitamin A was less pronounced, possibly due to systemic immune suppression and multiple nutritional deficiencies.59
4.3.2 Zinc supplementation and vaccine response
Studies in Bangladesh, India, and the DRC found that zinc supplementation enhances immune responses to OPV and rotavirus vaccines, likely due to its role in gut mucosal immunity and T-cell function.63
However, zinc had no effect on inactivated vaccines like hepatitis B and DTP, suggesting that its benefits are specific to mucosal immunity.64
4.3.3 Iron supplementation: A dDouble-edged sword?
While some studies found that iron supplementation improved vaccine seroconversion, others observed a paradoxical reduction in immunity.45 Excess iron may promote oxidative stress and bacterial infections, which could impair vaccine-induced immune responses.57
In the Haut-Lomami and Tanganyika studies, iron deficiency was prevalent, yet iron supplementation alone did not significantly enhance vaccine responses, suggesting the need for comprehensive nutritional rehabilitation.4
4.4.1 Integrating nutrition into routine immunization
Findings from Haut-Lomami and Tanganyika suggest that vaccination programs should be coupled with targeted nutritional interventions. This could be achieved through:
1. Providing vitamin A and zinc supplementation at the time of vaccination.
2. Screening for malnutrition during immunization campaigns.
3. Integrating delivery (vaccines + nutrition support at the same contact) offers best potential impact.
4.4.2 Prioritizing high-risk groups
• Children under 12 months benefited the most from nutritional interventions, indicating the need for early-life supplementation programs.
• Children with SAM require therapeutic feeding for recovery, but should still receive vaccines promptly due to high infection risk.
• However, research indicates that malnutrition adversely affects vaccine efficacy. For example, a study in Rio de Janeiro found that malnourished children had lower seroconversion rates after measles immunization compared to well-nourished children. Additionally, a systematic review highlighted malnutrition as a key factor impacting measles vaccine effectiveness. While these studies underscore the relationship between nutrition and vaccine response, further research is needed to determine the specific impact of nutritional rehabilitation on vaccine seroconversion rates in children recovering from SAM.51,65
4.4.3 Strengthening community-based nutrition programs
• Community health workers should actively screen and treat malnutrition in immunization settings.
• Nutritional counseling for mothers should be included in immunization campaigns.
The strength of the evidence varied across outcomes. While the impact of Vitamin A on measles seroconversion and zinc on OPV responses showed moderate certainty, the evidence for iron supplementation and for outcomes such as tetanus or general mortality was of low to very low certainty. This underscores the need for further rigorous trials in malnourished populations.
1. Heterogeneity in study designs – Included studies varied in intervention types, outcome definitions, and assessment methods, which may introduce bias. While randomized controlled trials (RCTs) were prioritized when available, high-quality observational studies were also retained to provide contextual relevance, particularly in regions where RCT data are scarce.
2. Limited longitudinal follow-up – Most studies assessed vaccine responses shortly after immunization, with few evaluating long-term immunity. This limits our ability to draw conclusions about sustained protection.
3. Restricted vaccine scope – Evidence was available mainly for oral polio vaccine (OPV), measles, rotavirus, and BCG. Data were sparse or lacking for other Expanded Programme on Immunization (EPI) vaccines, such as DTP, hepatitis B, Hib, and pneumococcal vaccines. As a result, caution is warranted when extrapolating findings to all vaccine types, particularly inactivated or subunit vaccines.
4. Geographic focus – Findings were concentrated in specific settings such as Haut-Lomami and Tanganyika. Although informative, they may not be generalizable to all provinces of the Democratic Republic of the Congo (DRC) or to other countries with different socio-economic and health system contexts.
5. Potential sources of bias – Despite efforts to include only high-quality studies, several biases may limit reliability. Publication bias remains a concern, as null or negative findings are less likely to be published, possibly inflating the observed benefits of nutritional interventions. Selective outcome reporting was noted in some studies, with only significant immunogenicity results presented, limiting comprehensive interpretation. Attrition bias due to missing data (e.g., loss to follow-up or incomplete baseline nutritional/serological profiles) was also common. These factors were explicitly considered in our GRADE assessments and underscore the urgent need for rigorously designed trials with transparent reporting of all outcomes, regardless of statistical significance.
1. Longitudinal studies assessing the long-term effects of nutritional interventions on vaccine immunity.
2. Randomized controlled trials evaluating combined micronutrient supplementation strategies.
3. Investigating the role of gut microbiota in modulating oral vaccine responses in malnourished children.
4. The timing of nutritional interventions appears to influence vaccine responses. Several studies suggest that supplementation administered concurrently with vaccination yields the most consistent improvement in immunogenicity, particularly for live oral vaccines such as OPV and measles. Pre-vaccination supplementation may help correct deficiencies that impair immune priming, while post-vaccination supplementation may support antibody maturation. However, few studies directly compare timing, and further research is needed to optimize scheduling for maximal vaccine efficacy. Vaccination should never be postponed in malnourished children.
This review confirms that nutritional interventions—particularly vitamin A, zinc, and comprehensive rehabilitation—enhance vaccine immunogenicity in malnourished children. However, vaccination must not be delayed. Findings from Haut-Lomami and Tanganyika reinforce the critical role of nutrition in improving vaccine responses, particularly for measles and OPV.
Policy implications:
• Nutritional supplementation should be integrated into routine immunization programs in high-risk regions.
• Live vaccines (measles, OPV) benefit the most from nutritional interventions, warranting targeted supplementation efforts.
• Children with SAM require therapeutic feeding for recovery, but should still receive vaccines promptly due to high infection risk. Vaccination should never be postponed in malnourished children.
By addressing both immunization and malnutrition simultaneously, health programs in the DRC and other LMICs can enhance vaccine efficacy, improve child survival, and accelerate progress towards global immunization goals.
Extended data supporting this article are available on Zenodo: doi: 10.5281/zenodo.17072723.68
This record includes:
• Harmonized Tables 1–3 with explanatory note (‘Tables_with_ExplanatoryNote.docx’)
• Study-level dataset of the 29 included studies (‘F1000_Vaccine_Review_Tables_V4_Cleaned.xlsx’)
• PRISMA 2020 flow diagram (‘Figure 1.jpg’)
Previous versions of the dataset remain accessible:
• doi:[10.5281/zenodo.15346825](https://doi.org/10.5281/zenodo.15346825)66
• doi:[10.5281/zenodo.15873743](https://doi.org/10.5281/zenodo.15873743)67
License:
Data is released under the Creative Commons Attribution 4.0 International license (CC BY 4.0).
The authors extend their sincere gratitude to the Ministry of Health of the Democratic Republic of Congo and the Provincial Health Authorities for their continuous support. We would also like to thank the various organizations and individuals whose valuable contributions and expertise have significantly enriched this research.
Views | Downloads | |
---|---|---|
F1000Research | - | - |
PubMed Central
Data from PMC are received and updated monthly.
|
- | - |
Competing Interests: No competing interests were disclosed.
Reviewer Expertise: Nutritional immunology
Competing Interests: No competing interests were disclosed.
Reviewer Expertise: Nutraceuticals, Pharmaceuticals
Are the rationale for, and objectives of, the Systematic Review clearly stated?
Partly
Are sufficient details of the methods and analysis provided to allow replication by others?
No
Is the statistical analysis and its interpretation appropriate?
I cannot comment. A qualified statistician is required.
Are the conclusions drawn adequately supported by the results presented in the review?
No
If this is a Living Systematic Review, is the ‘living’ method appropriate and is the search schedule clearly defined and justified? (‘Living Systematic Review’ or a variation of this term should be included in the title.)
Not applicable
References
1. Smith R: Investigating the previous studies of a fraudulent author. BMJ. 2005; 331 (7511): 288-291 Publisher Full TextCompeting Interests: No competing interests were disclosed.
Reviewer Expertise: I am a paediatrician, mainly doing clinical research. In my PhD I worked on the relationship between malnutrition infections and immune function, by assessing the effect of nutritional rehabilitation on thymus size in children with severe and moderate acute malnutrition. I also did a systematic review of the relationship between malnutrition and immune parameters.
Are the rationale for, and objectives of, the Systematic Review clearly stated?
Yes
Are sufficient details of the methods and analysis provided to allow replication by others?
Yes
Is the statistical analysis and its interpretation appropriate?
Yes
Are the conclusions drawn adequately supported by the results presented in the review?
Yes
If this is a Living Systematic Review, is the ‘living’ method appropriate and is the search schedule clearly defined and justified? (‘Living Systematic Review’ or a variation of this term should be included in the title.)
Not applicable
Competing Interests: No competing interests were disclosed.
Reviewer Expertise: Nutritional immunology
Are the rationale for, and objectives of, the Systematic Review clearly stated?
Yes
Are sufficient details of the methods and analysis provided to allow replication by others?
Yes
Is the statistical analysis and its interpretation appropriate?
Yes
Are the conclusions drawn adequately supported by the results presented in the review?
Yes
If this is a Living Systematic Review, is the ‘living’ method appropriate and is the search schedule clearly defined and justified? (‘Living Systematic Review’ or a variation of this term should be included in the title.)
No
Competing Interests: No competing interests were disclosed.
Reviewer Expertise: Nutraceuticals, Pharmaceuticals
Alongside their report, reviewers assign a status to the article:
Invited Reviewers | |||
---|---|---|---|
1 | 2 | 3 | |
Version 4 (revision) 11 Sep 25 |
|||
Version 3 (revision) 18 Jul 25 |
read | read | read |
Version 2 (revision) 20 Jun 25 |
read | ||
Version 1 20 May 25 |
read |
Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list:
Sign up for content alerts and receive a weekly or monthly email with all newly published articles
Already registered? Sign in
The email address should be the one you originally registered with F1000.
You registered with F1000 via Google, so we cannot reset your password.
To sign in, please click here.
If you still need help with your Google account password, please click here.
You registered with F1000 via Facebook, so we cannot reset your password.
To sign in, please click here.
If you still need help with your Facebook account password, please click here.
If your email address is registered with us, we will email you instructions to reset your password.
If you think you should have received this email but it has not arrived, please check your spam filters and/or contact for further assistance.
Comments on this article Comments (0)